Glaxo (GSK), SK bioscience’s COVID-19 Jab Enters Phase III Study
GlaxoSmithKline (GSK) and SK bioscience begin a phase III study on GBP510, the latter’s COVID-19 vaccine candidate. The study will compare GBP510 agai…
GlaxoSmithKline (GSK) and SK bioscience begin a phase III study on GBP510, the latter’s COVID-19 vaccine candidate. The study will compare GBP510 agai…